vs
Side-by-side financial comparison of Bausch & Lomb Corp (BLCO) and Domino's (DPZ). Click either name above to swap in a different company.
Bausch & Lomb Corp is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× Domino's). Domino's runs the higher net margin — 12.2% vs -4.1%, a 16.3% gap on every dollar of revenue. On growth, Bausch & Lomb Corp posted the faster year-over-year revenue change (9.8% vs 3.5%). Domino's produced more free cash flow last quarter ($147.0M vs $60.0M). Over the past eight quarters, Bausch & Lomb Corp's revenue compounded faster (13.1% CAGR vs 2.4%).
Bausch & Lomb is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.
Domino's Pizza, Inc. is an American multinational pizza restaurant chain founded in 1960. The corporation is Delaware-domiciled and headquartered at the Domino's Farms office park in Ann Arbor Township, near Ann Arbor, Michigan. As of 2018, Domino's had approximately 15,000 stores, with 5,649 in the United States, 1,500 in India, and 1,249 in the United Kingdom. Domino's has stores in more than 83 countries and 5,701 cities worldwide.
BLCO vs DPZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.2B |
| Net Profit | $-58.0M | $139.8M |
| Gross Margin | — | 40.4% |
| Operating Margin | 8.0% | 20.0% |
| Net Margin | -4.1% | 12.2% |
| Revenue YoY | 9.8% | 3.5% |
| Net Profit YoY | -1833.3% | -6.6% |
| EPS (diluted) | $-0.16 | $4.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B |
| Q1 26 | — | $139.8M | ||
| Q4 25 | $-58.0M | — | ||
| Q3 25 | $-28.0M | $139.3M | ||
| Q2 25 | $-62.0M | $131.1M | ||
| Q1 25 | $-212.0M | $149.7M | ||
| Q4 24 | $-3.0M | $169.4M | ||
| Q3 24 | $4.0M | $146.9M | ||
| Q2 24 | $-151.0M | $142.0M |
| Q1 26 | — | 40.4% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 40.1% | ||
| Q2 25 | — | 40.3% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 39.2% | ||
| Q2 24 | — | 39.8% |
| Q1 26 | — | 20.0% | ||
| Q4 25 | 8.0% | — | ||
| Q3 25 | 7.4% | 19.5% | ||
| Q2 25 | -0.9% | 19.7% | ||
| Q1 25 | -7.3% | 18.9% | ||
| Q4 24 | 6.8% | 19.0% | ||
| Q3 24 | 3.6% | 18.4% | ||
| Q2 24 | 2.1% | 17.9% |
| Q1 26 | — | 12.2% | ||
| Q4 25 | -4.1% | — | ||
| Q3 25 | -2.2% | 12.1% | ||
| Q2 25 | -4.9% | 11.4% | ||
| Q1 25 | -18.6% | 13.5% | ||
| Q4 24 | -0.2% | 11.7% | ||
| Q3 24 | 0.3% | 13.6% | ||
| Q2 24 | -12.4% | 12.9% |
| Q1 26 | — | $4.13 | ||
| Q4 25 | $-0.16 | — | ||
| Q3 25 | $-0.08 | $4.08 | ||
| Q2 25 | $-0.18 | $3.81 | ||
| Q1 25 | $-0.60 | $4.33 | ||
| Q4 24 | $-0.00 | $4.89 | ||
| Q3 24 | $0.01 | $4.19 | ||
| Q2 24 | $-0.43 | $4.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $383.0M | $232.9M |
| Total DebtLower is stronger | $5.0B | $4.9B |
| Stockholders' EquityBook value | $6.4B | — |
| Total Assets | $14.0B | $1.8B |
| Debt / EquityLower = less leverage | 0.78× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $232.9M | ||
| Q4 25 | $383.0M | — | ||
| Q3 25 | $310.0M | $139.7M | ||
| Q2 25 | $266.0M | $272.9M | ||
| Q1 25 | $202.0M | $304.3M | ||
| Q4 24 | $305.0M | $186.1M | ||
| Q3 24 | $329.0M | $189.1M | ||
| Q2 24 | $285.0M | $283.7M |
| Q1 26 | — | $4.9B | ||
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.0B | $4.8B | ||
| Q2 25 | $5.0B | $3.8B | ||
| Q1 25 | $4.8B | $3.8B | ||
| Q4 24 | $4.8B | $3.8B | ||
| Q3 24 | $4.6B | $5.0B | ||
| Q2 24 | $4.6B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $6.4B | — | ||
| Q3 25 | $6.4B | $-4.0B | ||
| Q2 25 | $6.4B | $-4.0B | ||
| Q1 25 | $6.4B | $-3.9B | ||
| Q4 24 | $6.5B | $-4.0B | ||
| Q3 24 | $6.6B | $-4.0B | ||
| Q2 24 | $6.5B | $-3.9B |
| Q1 26 | — | $1.8B | ||
| Q4 25 | $14.0B | — | ||
| Q3 25 | $13.8B | $1.7B | ||
| Q2 25 | $13.8B | $1.8B | ||
| Q1 25 | $13.4B | $1.9B | ||
| Q4 24 | $13.5B | $1.7B | ||
| Q3 24 | $13.5B | $1.8B | ||
| Q2 24 | $13.3B | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 0.76× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $136.0M | $162.0M |
| Free Cash FlowOCF − Capex | $60.0M | $147.0M |
| FCF MarginFCF / Revenue | 4.3% | 12.8% |
| Capex IntensityCapex / Revenue | 5.4% | 1.3% |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-66.0M | $625.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.0M | ||
| Q4 25 | $136.0M | — | ||
| Q3 25 | $137.0M | $185.4M | ||
| Q2 25 | $35.0M | $187.8M | ||
| Q1 25 | $-25.0M | $179.1M | ||
| Q4 24 | $22.0M | $178.0M | ||
| Q3 24 | $154.0M | $172.7M | ||
| Q2 24 | $15.0M | $150.7M |
| Q1 26 | — | $147.0M | ||
| Q4 25 | $60.0M | — | ||
| Q3 25 | $63.0M | $164.0M | ||
| Q2 25 | $-54.0M | $167.3M | ||
| Q1 25 | $-135.0M | $164.3M | ||
| Q4 24 | $-70.0M | $135.9M | ||
| Q3 24 | $94.0M | $145.6M | ||
| Q2 24 | $-57.0M | $127.2M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | 4.3% | — | ||
| Q3 25 | 4.9% | 14.3% | ||
| Q2 25 | -4.2% | 14.6% | ||
| Q1 25 | -11.9% | 14.8% | ||
| Q4 24 | -5.5% | 9.4% | ||
| Q3 24 | 7.9% | 13.5% | ||
| Q2 24 | -4.7% | 11.6% |
| Q1 26 | — | 1.3% | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 5.8% | 1.9% | ||
| Q2 25 | 7.0% | 1.8% | ||
| Q1 25 | 9.7% | 1.3% | ||
| Q4 24 | 7.2% | 2.9% | ||
| Q3 24 | 5.0% | 2.5% | ||
| Q2 24 | 5.9% | 2.1% |
| Q1 26 | — | 1.16× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.33× | ||
| Q2 25 | — | 1.43× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.05× | ||
| Q3 24 | 38.50× | 1.18× | ||
| Q2 24 | — | 1.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLCO
| Overthe Counter Products | $489.0M | 35% |
| Pharmaceuticals | $378.0M | 27% |
| Other | $263.0M | 19% |
| Surgical | $249.0M | 18% |
| Brandedand Other Generic Products | $14.0M | 1% |
| Other Revenues | $3.0M | 0% |
| Pharmaceutical Products | $2.0M | 0% |
DPZ
| Supply chain | $699.0M | 61% |
| U.S. franchise royalties and fees | $158.0M | 14% |
| U.S. franchise advertising | $130.5M | 11% |
| U.S. Company-owned stores | $82.1M | 7% |
| International franchise royalties and fees | $81.0M | 7% |
